NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 19, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
CoronavirusCovid19
Interventions
DEVICE

Soterix taVNS model 0125-LTE Stimulator - Active-Active Group

Participants will receive active taVNS stimulation for weeks 1-4 of the stimulation portion of this study.

DEVICE

Soterix taVNS model 0125-LTE Stimulator - Sham-Active Group

Participants will receive sham taVNS stimulation for weeks 1\&2 and active stimulation for weeks 3\&4 of the stimulation portion of this study.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

Medical University of South Carolina

OTHER

NCT04638673 - NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis | Biotech Hunter | Biotech Hunter